Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Xenon Pharmaceuticals ROE 2012-2018 | XENE

Current and historical return on equity (ROE) values for Xenon Pharmaceuticals (XENE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Xenon Pharmaceuticals ROE for the three months ending September 30, 2018 was -65.64%.
Xenon Pharmaceuticals ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.03B $0.11B -54.87%
2018-06-30 $-0.03B $0.05B -65.82%
2018-03-31 $-0.03B $0.03B -68.79%
2017-12-31 $-0.03B $0.04B -66.67%
2017-09-30 $-0.03B $0.04B -54.21%
2017-06-30 $-0.03B $0.05B -48.33%
2017-03-31 $-0.03B $0.06B -46.09%
2016-12-31 $-0.02B $0.06B -37.70%
2016-09-30 $-0.02B $0.07B -34.85%
2016-06-30 $-0.02B $0.05B -28.81%
2016-03-31 $-0.01B $0.06B -16.19%
2015-12-31 $-0.02B $0.06B -25.40%
2015-09-30 $-0.00B $0.06B -4.55%
2015-06-30 $0.01B $0.06B 8.51%
2015-03-31 $0.00B $0.06B 9.36%
2014-12-31 $0.01B $0.07B 48.15%
2014-09-30 $0.00B $0.04B 45.71%
2014-06-30 $0.00B $0.00B inf%
2014-03-31 $0.00B $0.00B 30.77%
2013-12-31 $0.00B $0.00B 30.77%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.203B $0.000B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Biogen (BIIB) United States $65.504B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $47.772B 63.99
Regeneron Pharmaceuticals (REGN) United States $45.961B 21.35
Illumina (ILMN) United States $44.432B 52.84
Alexion Pharmaceuticals (ALXN) United States $28.812B 17.86
Incyte (INCY) United States $17.998B 168.16
BioMarin Pharmaceutical (BMRN) United States $16.355B 0.00
Seattle Genetics (SGEN) United States $11.263B 0.00
Exact Sciences (EXAS) United States $10.517B 0.00
Sarepta Therapeutics (SRPT) United States $9.373B 0.00
QIAGEN (QGEN) Netherlands $8.817B 28.83
Alnylam Pharmaceuticals (ALNY) United States $8.541B 0.00
BeiGene (BGNE) Cayman Islands $8.254B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.417B 0.00
Bio-Techne Corp (TECH) United States $7.246B 48.82
Moderna (MRNA) United States $6.852B 0.00
Exelixis (EXEL) United States $6.383B 14.93
Amarin (AMRN) Ireland $5.664B 0.00
Alkermes (ALKS) Ireland $5.319B 0.00
Galapagos (GLPG) Belgium $5.211B 0.00
Array BioPharma (ARRY) United States $5.041B 0.00
Guardant Health (GH) United States $4.307B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.052B 0.00
Allogene Therapeutics (ALLO) United States $3.872B 0.00
Horizon Pharma Public (HZNP) Ireland $3.800B 15.63
Intercept Pharmaceuticals (ICPT) United States $3.486B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.372B 0.00
Emergent Biosolutions (EBS) United States $3.345B 28.18
Blueprint Medicines (BPMC) United States $3.303B 0.00
Ascendis Pharma (ASND) Denmark $2.993B 0.00
Genomic Health (GHDX) United States $2.985B 100.78
ACADIA Pharmaceuticals (ACAD) United States $2.874B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.873B 0.00
Immunomedics (IMMU) United States $2.725B 0.00
China Biologic Products (CBPO) China $2.666B 18.98
Global Blood Therapeutics (GBT) United States $2.649B 0.00
Repligen (RGEN) United States $2.610B 81.52
Reata Pharmaceuticals (RETA) United States $2.565B 0.00
Ligand Pharmaceuticals (LGND) United States $2.524B 18.13
Mirati Therapeutics (MRTX) United States $2.467B 0.00
Arena Pharmaceuticals (ARNA) United States $2.451B 0.00
Halozyme Therapeutics (HALO) United States $2.431B 54.26
Akcea Therapeutics (AKCA) United States $2.322B 0.00
Myriad Genetics (MYGN) United States $2.307B 23.49
Amicus Therapeutics (FOLD) United States $2.194B 0.00
Denali Therapeutics (DNLI) United States $2.039B 0.00
Insmed (INSM) United States $2.031B 0.00
Acceleron Pharma (XLRN) United States $1.948B 0.00
Spark Therapeutics (ONCE) United States $1.929B 0.00
Atara Biotherapeutics (ATRA) United States $1.838B 0.00
Medicines (MDCO) United States $1.813B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.785B 0.00
AnaptysBio (ANAB) United States $1.767B 0.00
MyoKardia (MYOK) United States $1.749B 0.00
NeoGenomics (NEO) United States $1.696B 139.62
CRISPR Therapeutics AG (CRSP) Switzerland $1.682B 0.00
REGENXBIO (RGNX) United States $1.677B 22.50
Zai Lab Unsponsored ADR (ZLAB) China $1.664B 0.00
Myovant Sciences (MYOV) United Kingdom $1.504B 0.00
Allakos (ALLK) United States $1.474B 0.00
Innoviva (INVA) United States $1.468B 4.05
UniQure (QURE) Netherlands $1.432B 0.00
ALECTOR INC (ALEC) United States $1.417B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.384B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.384B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.373B 0.00
Aimmune Therapeutics (AIMT) United States $1.351B 0.00
Cambrex (CBM) United States $1.289B 13.89
Clovis Oncology (CLVS) United States $1.285B 0.00
Lion Biotechnologies (IOVA) United States $1.260B 0.00
GOSSAMER BIO (GOSS) United States $1.243B 0.00
Codexis (CDXS) United States $1.178B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.123B 0.00
WAVE Life Sciences (WVE) Singapore $1.113B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.103B 0.00
Audentes Therapeutics (BOLD) United States $1.068B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.056B 42.85
Rubius Therapeutics (RUBY) United States $1.049B 0.00
Puma Biotechnology (PBYI) United States $1.027B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.013B 0.00
Editas Medicine (EDIT) United States $0.967B 0.00
Epizyme (EPZM) United States $0.964B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.955B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.951B 0.00
Coherus BioSciences (CHRS) United States $0.938B 0.00
Fate Therapeutics (FATE) United States $0.932B 0.00
Sangamo Therapeutics (SGMO) United States $0.890B 0.00
Retrophin (RTRX) United States $0.871B 0.00
Athenex (ATNX) United States $0.858B 0.00
Vericel (VCEL) United States $0.838B 0.00
CytomX Therapeutics (CTMX) United States $0.818B 0.00
Apellis Pharmaceuticals (APLS) United States $0.808B 0.00
Novavax (NVAX) United States $0.800B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.787B 0.00
InflaRx (IFRX) Germany $0.772B 0.00
G1 THERAPEUTICS (GTHX) United States $0.765B 0.00
Heska (HSKA) United States $0.749B 61.26
Cellectis (CLLS) France $0.746B 0.00
Principia Biopharma (PRNB) United States $0.745B 0.00
Intra-Cellular Therapies (ITCI) United States $0.740B 0.00
ANI Pharmaceuticals (ANIP) United States $0.720B 13.77
Arvinas (ARVN) United States $0.715B 0.00
Dynavax Technologies (DVAX) United States $0.688B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.674B 0.00
Cara Therapeutics (CARA) United States $0.664B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.651B 0.00
Acorda Therapeutics (ACOR) United States $0.647B 8.40
Viking Therapeutics (VKTX) United States $0.645B 0.00
RA PHARMCTL INC (RARX) United States $0.632B 0.00
Twist Bioscience (TWST) United States $0.621B 0.00
Synthorx (THOR) United States $0.599B 0.00
Intellia Therapeutics (NTLA) United States $0.595B 0.00
Kura Oncology (KURA) United States $0.580B 0.00
Anika Therapeutics (ANIK) United States $0.568B 23.53
Lexicon Pharmaceuticals (LXRX) United States $0.562B 0.00
UROGEN PHARMA (URGN) Israel $0.556B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.553B 0.00
Osiris Therapeutics (OSIR) United States $0.547B 0.00
Eidos Therapeutics (EIDX) United States $0.530B 0.00
Prothena (PRTA) Ireland $0.530B 0.00
Arcus Biosciences (RCUS) United States $0.498B 0.00
UNITY Biotechnology (UBX) $0.497B 0.00
Zymeworks (ZYME) Canada $0.495B 0.00
PDL BioPharma (PDLI) United States $0.495B 8.07
ProQR Therapeutics (PRQR) Netherlands $0.484B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.471B 0.00
Zealand Pharma (ZEAL) Denmark $0.462B 5.09
DBV Technologies (DBVT) France $0.451B 0.00
Senesco Technologies (ELOX) United States $0.448B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.445B 0.00
Scholar Rock Holding (SRRK) United States $0.439B 0.00
ObsEva SA (OBSV) Switzerland $0.437B 0.00
Replimune (REPL) United States $0.429B 0.00
Cytokineticsorporated (CYTK) United States $0.421B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.415B 0.00
Five Prime Therapeutics (FPRX) United States $0.414B 0.00
OSMOTICA PHARM (OSMT) United States $0.412B 0.00
Kezar Life Sciences (KZR) United States $0.411B 0.00
BeyondSpring (BYSI) United States $0.402B 0.00
Mesoblast (MESO) Australia $0.396B 0.00
Agenus (AGEN) United States $0.380B 0.00
MediciNova (MNOV) United States $0.375B 0.00
AVROBIO (AVRO) United States $0.371B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.370B 0.00
Sinovac Biotech (SVA) China $0.369B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.367B 0.00
Stemline Therapeutics (STML) United States $0.367B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Cellular Biomedicine (CBMG) United States $0.364B 0.00
Inovio Pharmaceuticals (INO) United States $0.352B 0.00
MeiraGTx Holdings (MGTX) United States $0.351B 0.00
BioDelivery Sciences (BDSI) United States $0.341B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.338B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.329B 0.00
Urovant Sciences (UROV) United States $0.327B 0.00
Abeona Therapeutics (ABEO) United States $0.320B 0.00
Albireo Pharma (ALBO) United States $0.312B 0.00
Evelo Biosciences (EVLO) United States $0.309B 0.00
Aduro Biotech (ADRO) United States $0.308B 0.00
XBiotech (XBIT) United States $0.308B 0.00
Enochian BioSciences (ENOB) United States $0.296B 0.00
Magenta Therapeutics (MGTA) United States $0.294B 0.00
Geron (GERN) United States $0.291B 0.00
Solid Biosciences (SLDB) United States $0.291B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.282B 0.00
Intec Pharma (NTEC) Israel $0.280B 0.00
Constellation Pharmaceuticals (CNST) United States $0.279B 0.00
Sorrento Therapeutics (SRNE) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.266B 0.00
AC Immune SA (ACIU) Switzerland $0.264B 0.00
Merus (MRUS) Netherlands $0.263B 0.00
Kala Pharmaceuticals (KALA) United States $0.261B 0.00
Axsome Therapeutics (AXSM) United States $0.256B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.253B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.252B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Celcuity (CELC) United States $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.245B 0.00
Verastem (VSTM) United States $0.244B 0.00
MannKind (MNKD) United States $0.238B 0.00
Synlogic (SYBX) United States $0.237B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Kamada (KMDA) Israel $0.235B 10.60
ResTORbio (TORC) United States $0.233B 0.00
Liquidia Technologies (LQDA) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Adverum Biotechnologies (ADVM) United States $0.232B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.232B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
TOCAGEN INC (TOCA) United States $0.217B 0.00
Athersys (ATHX) United States $0.215B 0.00
ChromaDex (CDXC) United States $0.213B 0.00
Arbutus Biopharma (ABUS) Canada $0.209B 0.00
Cerecor (CERC) United States $0.209B 0.00
LogicBio Therapeutics (LOGC) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.206B 0.00
Celyad SA (CYAD) Belgium $0.203B 0.00
CorMedix Inc (CRMD) United States $0.200B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
Axovant Sciences (AXGT) United Kingdom $0.187B 0.00
Aptinyx (APTX) United States $0.186B 0.00
ADMA Biologics Inc (ADMA) United States $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Protagonist Therapeutics (PTGX) United States $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.174B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Menlo Therapeutics (MNLO) United States $0.166B 0.00
BioTime (BTX) United States $0.161B 0.00
Palatin Technologies (PTN) United States $0.161B 79.24
VBI Vaccines (VBIV) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.156B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Proteostasis Therapeutics (PTI) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.149B 0.00
OvaScience (MLND) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.146B 0.00
BioXcel Therapeutics (BTAI) United States $0.138B 0.00
Cohbar (CWBR) United States $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.132B 0.00
Pfenex (PFNX) United States $0.130B 0.00
Cue Biopharma (CUE) United States $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.125B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
Trevena (TRVN) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.122B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.122B 0.00
Equillium (EQ) United States $0.120B 0.00
XOMA (XOMA) United States $0.119B 0.00
Pluristem Therapeutics (PSTI) Israel $0.118B 0.00
Mustang Bio (MBIO) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
VolitionRX (VNRX) Singapore $0.101B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.092B 0.00
NantKwest (NK) United States $0.090B 0.00
Signal Genetics (MGEN) United States $0.089B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cel-Sci (CVM) United States $0.082B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
Orgenesis (ORGS) United States $0.080B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
PHASEBIO PHARMA (PHAS) United States $0.077B 0.00
Protalix BioTherapeutics (PLX) Israel $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
Alimera Sciences (ALIM) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.073B 0.00
INMUNE BIO INC (INMB) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Idera Pharmaceuticals (IDRA) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
AEterna Zentaris (AEZS) United States $0.067B 12.75
Celldex Therapeutics (CLDX) United States $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
OVID THERAPEUTC (OVID) United States $0.063B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.063B 0.00
Evogene (EVGN) Israel $0.061B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
ARAVIVE, INC (ARAV) United States $0.059B 5.15
Proteon Therapeutics (PRTO) United States $0.058B 0.00
VIVUS (VVUS) United States $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Ophthotech (OPHT) United States $0.056B 0.00
ScPharmaceuticals (SCPH) United States $0.054B 0.00
Asterias Biotherapeutics (AST) United States $0.053B 0.00
Vaccinex (VCNX) United States $0.053B 0.00
Alcobra (ARCT) United States $0.052B 0.00
Entera Bio (ENTX) Israel $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Eyenovia (EYEN) United States $0.050B 0.00
Bellerophon Therapeutics (BLPH) United States $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.044B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.039B 0.00
Arsanis (ASNS) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Curis (CRIS) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Sophiris Bio (SPHS) United States $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.033B 5.31
Motif Bio Plc (MTFB) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
TRACON Pharmaceuticals (TCON) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
AZURRX BIOPHARM (AZRX) United States $0.029B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.027B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Adial Pharmaceuticals (ADIL) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Vical (VICL) United States $0.022B 0.00
GTx (GTXI) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Soligenix (SNGX) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.49
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.014B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Neuralstem (CUR) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00